Health Care Up On Defensive Bias -- Health Care Roundup

Health-care companies ticked up as traders rotated into defensive sectors.

Pfizer shares rose amid signs that the Food and Drug Administration would approve its booster for all U.S. adults. Separately, Pfizer said it's looking for a new chief financial officer following the retirement of its longtime chief financial officer, Frank D'Amelio.

The U.S. government has agreed to buy more doses of an antibody drug for the early treatment of Covid-19 developed by British drug giant GlaxoSmithKline and Vir Biotechnology, bringing its total order to nearly $1 billion for a treatment found to reduce the risk of hospitalization.

Siemens Healthineers set double-digit earnings-per-share growth targets for fiscal years 2023 to 2025.

 Write to Rob Curran at [e-mail] 

(END) Dow Jones Newswires

11-17-21 1640ET